Aktive Positionen von Lloyd Sanders
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Epic Sciences, Inc.
 Epic Sciences, Inc. Medical SpecialtiesHealth Technology Epic Sciences, Inc. develops novel diagnostics to the treatment and management of cancer. It develops sensitive diagnostic tests to molecularly characterize circulating tumor cells in the blood. The firm also offers fluid-phase biopsy that identifies rare cell of interest in the blood; and provides cancer management through earlier diagnosis, staging and therapeutic selections. The company was founded by David M. Nelson in 2008 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | 25.03.2019 | - |
| Vorstandsvorsitzender | 25.03.2019 | - | |
| Präsident | 25.03.2019 | - |
Karriereverlauf von Lloyd Sanders
Ehemalige bekannte Positionen von Lloyd Sanders
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Mylan Specialty LP
 Mylan Specialty LP Pharmaceuticals: MajorHealth Technology Mylan Specialty LP develops, manufactures, and markets respiratory disease & allergy treatment products. The company was founded in 1978 and is headquartered in Morgantown, WV. | Geschäftsführer | 06.05.2011 | - |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Chief Operating Officer | 1 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Mylan Specialty LP
Mylan Specialty LP Pharmaceuticals: MajorHealth Technology Mylan Specialty LP develops, manufactures, and markets respiratory disease & allergy treatment products. The company was founded in 1978 and is headquartered in Morgantown, WV. | Health Technology |
Epic Sciences, Inc.
Epic Sciences, Inc. Medical SpecialtiesHealth Technology Epic Sciences, Inc. develops novel diagnostics to the treatment and management of cancer. It develops sensitive diagnostic tests to molecularly characterize circulating tumor cells in the blood. The firm also offers fluid-phase biopsy that identifies rare cell of interest in the blood; and provides cancer management through earlier diagnosis, staging and therapeutic selections. The company was founded by David M. Nelson in 2008 and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Lloyd Sanders
- Erfahrung
